Navigation Links
Researchers identify new pathway, enhancing tamoxifen to tame aggressive breast cancer
Date:4/23/2013

Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.

The research, published in the journal EMBO Molecular Medicine, is a promising development for women with basal-like breast cancer, sometimes known as triple-negative disease. This subtype has a poor prognosis because it is notoriously resistant to treatment. In fact, basal-like cancers lack the three most common breast cancer biomarkers the estrogen receptor, the progesterone receptor, and theHer2/neu receptor and without these receptors, the usual front-line treatments are not effective.

Until recently, tamoxifen was known primarily for its ability to block estrogen receptors on the outside of cancer cells. However, new studies have suggested that when tamoxifen is given in higher doses, it works through a second mechanism of action independent of the estrogen receptor. This second mechanism was the focus of the Rochester laboratory.

Led by doctoral student Hsing-Yu Chen and Mark Noble, Ph.D., professor of Biomedical Genetics at URMC, the team studied the molecular mechanism that allows basal-like breast cancer cells to escape the secondary effects of tamoxifen, and discovered that two proteins are critical in this escape. One protein, called c-Cbl, controls the levels of multiple receptors that are critical for cancer cell function. A second protein, Cdc42, can inhibit c-Cbl and is responsible for the tumor's underlying resistance.

The team also discovered that targeting Cdc42 and thus inhibiting the inhibitor - with an experimental drug compound known as ML141 restored c-Cbl's normal function. Through additional work in animal models and in human cell cultures, the team demonstrated that when ML141 is paired with tamoxifen, it enhances the a
'/>"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Md. (PRWEB) May 21, 2015 The ... the University of Maryland, Baltimore Commercial Advisory Board has ... Maryland Health Care System as one of two $50,000 ... their ankle robot research, known as Anklebot. Developed ... Excellence, in collaboration with the University of Maryland School ...
(Date:5/21/2015)... 21, 2015 Bird B Gone, the leader ... recently added new sizes of the Bird Spike 2001 to ... stainless steel bird spike is specifically designed to reduce ... on roof lines, parapet walls, I-beams, window ledges and more. ... 100 foot boxes, allowing customers to buy the right amount ...
(Date:5/21/2015)... ARBOR, Mich. (PRWEB) May 21, 2015 ... the opposite effect on those with celiac disease according ... More than half of the probiotics tested in the ... in foods and dietary supplements and cause gastrointestinal inflammation ... , Companies aiming to gain consumer trust in gluten-free ...
(Date:5/21/2015)... An existing anti-stroke drug is an effective treatment ... mucus overproduction, improve bacterial clearance and reduce hearing ... and the University of Rochester. , The findings, ... could result in a novel, non-antibiotic treatment for ... drug delivery. Vinpocetine, the drug involved in the ...
(Date:5/21/2015)... 2015 Louis Kraml, CEO of Bingham ... new project and website—CancerTreatmentInfo.org. , With over 40 years ... about how vicious and insidious cancer can be, Mr. ... being treated and cared for. As such, he founded ... safe place where cancer patients, survivors, and family members ...
Breaking Medicine News(10 mins):Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 2Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 3
... , MORRISTOWN, N.J., July 28 Watson Pharmaceuticals, ... and specialty branded pharmaceuticals, today announced a license agreement with ... generic version of Ferrlecit (sodium ferric gluconate complex in sucrose ... anemia in hemodialysis patients receiving supplemental epoetin therapy. , ...
... pose no great risk to most people; consumer organization aghast ... health authorities on Tuesday placed tighter safety controls on ... and Drug Administration will now categorize the fillings as Class ... risk. Class II devices usually carry some kind of precautions ...
... , , 100% Oxygen Environment ... , SEATTLE, July 28 Northwest Hospital & Medical ... chambers and the launch of hyperbaric oxygen therapy services offered through ... , Hyperbaric oxygen chambers create a 100% oxygen environment, ...
... bypass could be a cause, expert says, , TUESDAY, July ... could be a severe shortage of cardiothoracic surgeons at a ... for surgical procedures that fall under their purview, a new ... of care and delays in care for people needing heart ...
... , , AVON, Conn., July ... its Avon facility,s certification to the international management system standard ... OFS Specialty Photonics Division facilities have maintained ISO 9001 certification ... manufacturing. The Avon facility has taken the additional step ...
... , , WASHINGTON, July 28 ... Action, the legislative lobbying arm of Family Research Council, ... to President Obama,s proposed government takeover of the health care system. ... leaders to discuss the moral, ethical, and financial dangers of President ...
Cached Medicine News:Health News:Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R) 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 3Health News:FDA Calls for Stricter Controls on Mercury Fillings 4Health News:Northwest Hospital Introduces Hyperbaric Oxygen Therapy 2Health News:Heart Surgeon Shortage Predicted 2Health News:Heart Surgeon Shortage Predicted 3Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 2Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 3
(Date:5/21/2015)... 2015 Increasing requirements, including rising surface ... gaskets indispensable in the chemical and pharmaceutical industries. ... pose major challenges to their performance. Freudenberg-NOK Sealing ... different materials whose scope covers the given requirements ... white FG-360, based on DIN 28091-3, is completely ...
(Date:5/21/2015)... , May 21, 2015  BioClinica®, Inc., ... provider, today announced it has partnered with Kinapse ... clinical trials using BioClinica,s Compass Intelligent Monitoring solution. ... can make a real difference in clinical research," ... excited about this collaboration as it helps move ...
(Date:5/21/2015)...  AbbVie (NYSE: ABBV ) announced today the ... announced offer to acquire each outstanding share of common ... cash and AbbVie common stock, as described in the ... and Exchange Commission by AbbVie on March 23, 2015, ... offer will expire at 5:00 p.m., New ...
Breaking Medicine Technology:Flat gaskets for especially demanding applications in the processing industry 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4
... The U.S. Food and Drug Administration today approved ... thyroid cancer who are ineligible for surgery and who ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... gland, which is located in the neck. Medullary thyroid ...
... Pure Biomed LLC has launched a full line ... for quick, temporary relief of nerve pain caused by ... damage.  Reunion is the only full line of skin ... Reunion products were developed from the ground up in ...
Cached Medicine Technology:FDA Approves New Treatment for Rare Form of Thyroid Cancer 2FDA Approves New Treatment for Rare Form of Thyroid Cancer 3Affordable Nerve Pain Treatment Now Available in the U.S. 2
McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Castroviejo tying forceps, straight....
Moria tying forceps are straight, very delicate platforms for 10-0 and 11-0 monofilament. Platforms fully meet to hold suture firmly....
Medicine Products: